Lexaria Bioscience Corp. (LEXX)
1.13
+0.04
(+3.67%)
USD |
NASDAQ |
Dec 09, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Market Cap: 25.12M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 103.68M |
| Aurinia Pharmaceuticals, Inc. | 2.047B |
| Edesa Biotech, Inc. | 12.58M |
| Xenon Pharmaceuticals, Inc. | 3.363B |
| ProMIS Neurosciences, Inc. | 17.49M |
Market Cap Related Metrics
| PS Ratio | 28.83 |
| PEG Ratio | -0.0382 |
| Price to Book Value | 8.401 |
| Price | 1.13 |
| Earnings Yield | -58.58% |
| PEGY Ratio | -0.0382 |